REGN

REGENERON PHARMACEUTICALS, INC.

Health Care · Biotechnology

$144.78 sample

+1.64 (+1.15%) 1D

Market cap

$365.0B

Price as of

2026-10-15

Latest filing

8-K

Alerts

8

Price$144.78 +7.94% 3M daily closessample

149.28131.84

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider buy: 10% owner
Oct 01INSInsider sell: General Counsel
Sep 23INSInsider buy: EVP, Operations
Sep 18INSInsider sell: Chief Executive Officer
Sep 10INSInsider buy: Chief Executive Officer
Sep 02INSInsider buy: 10% owner
Aug 25INSInsider buy: EVP, Operations
Aug 14INSInsider sell: EVP, Operations

Sign up to see the real REGN record →

Company facts

SEC EDGAR registration

Name: REGENERON PHARMACEUTICALS, INC.
Sector: Health Care
Industry: Biotechnology
Smart-money score: -33sample, -100 to +100
Reporting currency: USD

Who is positioning in REGN

sample

Insiders: 14 insider transactions over 90 days, net selling, $349.5M
Congress: 5 members traded over 90 days
Institutions · 13F: 28 funds hold $2.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$15.2B +18.5% y/y

Q4 2024Q3 2026

Inventory$9.2B +9.1% y/y

Q4 2024Q3 2026

Accounts receivable$6.6B +3.8% y/y

Q4 2024Q3 2026

Total debt$18.3B +15.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $244.4B +8.2% 3M
Sample peer B: $172.7B -11.4% 3M
Sample peer C: $337.1B +4.8% 3M
Sample peer D: $61.3B +6.2% 3M
Sample peer E: $145.9B -3.8% 3M